Back to results
US 12,698,341 B2Granted
Antigen binding domains that bind to mesothelin (MSLN)
AssigneeXencor, Inc.
InventorsJohn R. Desjarlais, Matthew Bernett, Michael Hedvat, Veronica Gusti Zeng, Matthew S. Faber
Life of this patent
Estimating the term…
Abstract
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Mesothelin (MSLN).
Claims6
A mesothelin (MSLN) antigen binding domain comprising a variable heavy domain having at least 90% identity to the amino acid sequence of SEQ ID NO:
- 241 and a variable light domain having at least 90% identity to the amino acid sequence of SEQ ID NO:
- 245.
An antibody comprising a mesothelin (MSLN) antigen binding domain comprising a variable heavy domain having at least 90% identity to the amino acid sequence of SEQ ID NO:
- 241 and a variable light domain having at least 90% identity to the amino acid sequence of SEQ ID NO:
- 245.
Dependencies are inferred from the claim text.